Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
did have a mild case of shingles after the first vaccine; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: did have a mild case of shingles after the first vaccine). The outcome of the shingles was not reported. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 04-APR-2025 This case was reported by a patient via interactive digital media. The patient reported that he/she had the Shingles vaccine twice and had a mild case of shingles after the first vaccine. The patient family member had it in her eye still being followed by the ophthalmologist. Further, stated that shingles was not a joke. This case is linked with US2025AMR041385, reported by same reporter for different patient.; Sender's Comments: US-GSK-US2025AMR041385:same reporter different patient